Find out more

Find out more about the work of our committee sub-groups and forums by clicking the logos below. These include The British Viral Hepatitis Group, British Association for the Study of the Liver Nurse Forum and the British Liver Transplant Group.

The British Viral Hepatitis aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.

British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care.

The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development.




BASL is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. Your Annual subscription is used to organise the Annual Meeting held each September.

Members of BASL receive the following benefits:

  • discounted registration rates for the annual meeting and other relevant meetings
  • eligibility for the BASL Travel Awards (for members below status of Senior Lecturer or Consultant to allow presentation of high-quality UK liver research at International meetings, including the American Association for the Study of Liver Disease)
  • eligibility for the prestigious Dame Sheila Sherlock Award (to an emerging researcher in the field of liver disease, for members below status of Senior Lecturer or consultant). Applications are usually submitted to the BASL Committee three months prior to the annual meeting - details are announced.

Click here to find out more about joining us.


15/11/17 Alcohol Health Alliance Response to Supreme Court Judgement on Minimum Unit Pricing
News Type: BASL News

Responding to the UK Supreme Court judgment that minimum unit pricing is legal, Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK, said:

“We are delighted with the Supreme Court’s judgement that minimum unit pricing is legal and can be implemented in Scotland. The decision today represents a great victory for the health of the public.

“Five years ago the legislation introducing MUP passed through the Scottish Parliament without opposition. It has taken five years to implement for the simple reason that the Scottish Whisky Association and others chose to challenge it in the courts. In that time many families have needlessly suffered the pain and heartache of losing a loved one.

“This decision has implications far beyond Scotland. Wales, Northern Ireland and the Republic of Ireland are now clear to progress their own plans for minimum unit pricing.

“The spotlight should now fall on England, where cheap alcohol is also causing considerable damage. Over 23,000 people in England die every year from alcohol-related causes, many of them coming from the poorest and most vulnerable sections of society. We urge the Westminster Government to act now and introduce the measure in England. A failure to do so will needlessly cost more lives.”


Information on the AHA’s campaign for minimum unit pricing, along with facts and figures on the estimated impacts of MUP, is available on the AHA website: . 

About the Alcohol Health Alliance UK
The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:
- Highlight the rising levels of alcohol-related health harm
- Propose evidence-based solutions to reduce this harm
- Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at  or on 0203 075 1726.

27/10/17 Change to the Definition of Alcohol Deaths
News Type: BASL News

Commenting on the editorial published in The Lancet Gastroenterology & Hepatology on the new definition of alcohol mortality proposed by Office for National Statistics (ONS), Professor Sir Ian Gilmore, chair of the Alcohol Health Alliance UK, said:

“We agree entirely with the concerns outlined in The Lancet Gastroenterology & Hepatology about the revised definition for alcohol deaths from the ONS.

“The new definition will mean that a high number of liver disease deaths where we know that alcohol is the cause will no longer be recorded as being linked to alcohol.

“This reduction will give the wrong impression to the public that alcohol deaths are going down, when in fact the burden of alcohol on our nation’s health and health service is growing, with alcohol-related hospital admissions going up, and liver disease rates on the rise.

“Medical experts across the country have warned that it is premature for the ONS to alter the definition in the way it has proposed. The reasons are technical, but it comes down to the fact that more research is needed on the exact link between alcohol and certain categories of liver disease deaths.

“We recommend that the ONS hits the pause button on the work it is doing to alter the definition of alcohol deaths, until the necessary research has been done. This research could be done quickly and cheaply, in a handful of liver centres across the country.”

The editorial is available by clicking > here.

About the Alcohol Health Alliance UK

The Alcohol Health Alliance UK (AHA) is a group of over 50 organisations including the Royal College of Physicians, Royal College of GPs, British Medical Association, Alcohol Concern and the Institute of Alcohol Studies. The AHA works together to:
- Highlight the rising levels of alcohol-related health harm
- Propose evidence-based solutions to reduce this harm
- Influence decision makers to take positive action to address the damage caused by alcohol misuse

For further information, please contact Matt Chorley, the AHA’s Policy and Communications Officer, at or on 0203 075 1726.

27/10/17 Medical Research Foundation Funding for Viral Hepatitis Researchers - application deadline 10th November
News Type: BASL News

The Medical Research Foundation have recently launched a funding opportunity focused on Viral Hepatitis research. Due to overwhelming demand the deadline has been extended for applications to Friday 10th November 2017.

This funding is aimed at Mid-Career researchers, who are making the transition to independence, and will support research that will increase the understanding of the disease mechanisms underlying viral hepatitis.

This competition is open to all UK researchers at eligible institutions (UK HEIs, Research Council research institutes, hospitals, and other independent research organisations). Applicants must hold a PhD, DPhil or MD and be in the process of, or be ready for, transition to research independence.

There is up to £1.6 million available in this competition and applicants may apply for up to £300,000 to support their research, over a maximum of a three year period.

The application process is now open and the deadline has been extended to Friday 10th November 2017.

More information can be found on the Medical Research Foundation website > here.

25/10/17 IQILS Update
News Type: BASL News

Improving Quality in Liver Services (IQILS) is a new scheme based on the work of the LiverQuest project.

The project led by the RCP London and supported by BASL and the BSG supports the national strategy to improve medical liver services for patients.

IQILS is run by the Royal College of Physicians (RCP) working in partnership with the Liver community, the professional bodies, societies and patient groups.

IQILS is open to all liver services across the UK and currently 18 services have signed up and are working towards accreditation. A list of these services can be viewed on the RCP website here; .

Should you have any questions about IQILS please contact Madeline Corrigan, IQILS Programme Manager at the RCP at .

22/09/17 Press Release - British Liver Nurses' Association (BLNA) Launch
News Type: Nurse News

We are pleased to announce the official launch of the British Liver Nurses Association (BLNA). As you may already be aware, the BLNA is the new national liver nurses group, founded following the merger of the British Liver Nurses Forum (BLNF) and the British Association for the Study of the Liver Nurses Forum (BASLNF). 

After 2-3 years of collaborative working, the BLNF and BASLNF members reached a stage where their aims and objectives for liver nursing were such that it was agreed to unite so as to provide one powerful voice to raise the profile of liver nursing, across the UK.

The BLNA is a professional nursing association run by its members for its members and promises to continue to offer professional support for nurses working within all fields of liver disease. The BLNA will take forward the shared values and strengths from both BASLNF and BLNF and together with and on behalf of its members, will ensure opportunities are available to share best practice, as well as attend educational meetings, with the ultimate aim of improving standards of liver care to all people affected by liver disease.

The BLNA, also promises to continue to maintain and develop strong links with all those professional and charitable groups, locally, nationally and internationally. We look forward to working with you all, in the future.

Kind regards,

Fiona Fry and Michelle Clayton.
Co-chairs BLNA

18/09/17 Apply for the role of health service representative or lay member of Technology Appraisal or Highly Specialised Technologies Appeal Panels
News Type: BASL News

The National Institute for Health and Care Excellence (NICE) is looking to appoint a number of people with the necessary experience and skills to fulfill the following roles:

• Health service representative – up to 3 people
• Lay member – 2 people

The appeal panel is responsible for hearing appeals against our draft final recommendations in the technology appraisal (new drugs and other technologies used in the NHS) and highly specialised technologies (the evaluation of technologies for treating patients with very rare diseases and very complex healthcare needs) programmes.

When an appeal is submitted an appeal panel comprising five members is drawn from those appointed to hear NICE appeals.

The health service representative must hold an active registration with the appropriate professional body (including for doctors, a licence to practise).

The lay representative must be a patient or carer, or a member of an organisation that represents patients or carers.

Appointees will need to have an ability to draw out and articulate a balanced view on the issues arising from an appeal that are relevant to patients, carers and/or members of the public, and an ability to critique and weigh up competing arguments and make decisions (sometimes difficult ones) in meetings that are open to the public. Appeal panels are established infrequently and appointees may only need to sit on a panel two to three times a year.

NICE welcome applicants from all interested parties. For further information on the role and how apply please refer to the NICE website: . Alternatively you can contact Maria Pitan, Project Manager – Corporate Office by email .

Deadline for applications is midnight on Monday 2 October 2017.

15/09/17 PSC Support and UK-PSC are partnering on a funding call for UK projects using UK-PSC data
News Type: BASL News

PSC Support and UK-PSC are inviting applications from UK-based investigators to conduct, ethically approved, biomarker based, research using serum samples collected for the UK-PSC biobank during the recent re-consenting effort. Clinical data is available and ethics exist for the successful research teams to collect further data.

Grant Amount and Scope  - two grants of up to £15,000 each will be awarded.

Pilot and feasibility work to enable larger grant applications will be considered.

Your research project must address PSC Support Research Priorities and have anticipated clear patient benefit, as regards potential use of biomarkers in PSC management.

PSC Support is an NIHR non-commercial Partner. Appropriate research studies funded through 'PSC Support Research Project Grants' are now automatically eligible for NIHR Clinical Research Network (CRN) support and therefore entitled to access NHS support via the NIHR Clinical Research Network.

Applicants should send their completed PSC Support Application Form together with additional relevant study investigator CVs, ethics approval and letter of support from the relevant Head of Department to .

UK-PSC Biobank
At present we have just under 900 serum samples stored in the Cambridge Bioresource. Serum is aliquoted and just under 2/3rds of the samples come from pre-transplant patients with PSC.

Application Deadline - 31 October 2017

Expected Decision Date - 01 December 2017

For more details visit .  

14/09/17 Liver Disease Atlas - News Release
News Type: BASL News

Please find below the news release that has gone out today to coincide with the publication of PHE Liver Disease Atlas.

BASL has been involved in helping put this together.

Download Liver disease atlas press release v11 13092017.pdf


11/12/17 Gastroenterology and Hepatology in pregnancy conference - RCP London
News Type: Other Events

The Gastroenterology and Hepatology in pregnancy conference is a one day conference taking place at the Royal College of Physicians in London on 11th December 2017.

The conference will  cover both common ailments associated with pregnancy, as well as those patients with ongoing gut and liver conditions who become pregnant.

Who should attend?

  • Obstetricians
  • Gasterentologists
  • Heptologists
  • GPs
  • Nurse specialists
  • Specialists registrars

Download a copy of the programme here:   Download GastroenterologyandHepatologyinPregancyprogrammeDec17.pdf

Further information can be found by clicking > here

14/12/17 BASL – Wilson’s Disease Special Interest Group (SIG)
News Type: BASL Events

We would like to invite any interested BASL members to join the Wilson’s Disease Special Interest Group (SIG).

The inaugural meeting of the group is taking place on 14th December 2017 from 09.30 - 16.30.

Venue: Burroughs Room, Wellcome Collection, 183 Euston Road, London NW1 2BE, UK.

A draft programme is available >  Download Draft Programme-BASL Wilson Disease SIG-14.12.17.pdf

Please note that this is not an educational event per se and members should have an active interest in Wilson’s / able to contribute to the group. Neurologists and clinical chemists/geneticists with known interest in Wilson’s have been approached but we welcome more.

If you are a BASL member and are unable to attend the meeting on 14th December but wish to join the group then we would be happy to include you in any future circulations. There is an expectation of a further meeting towards the end of 2018.

The formal Chair of the Wilson’s SIG will be decided in due course but for the purpose of getting the initial meeting set up Dr James Dooley has been instrumental and Dr Bill Griffiths has been given an overseeing task by the outgoing BASL President.

If you are a BASL member and interested in joining the Wilson’s disease SIG and attending the meeting please contact Dr Griffiths directly at . 

25/01/18 - 26/01/18 22nd Advanced Gastroenterology & Hepatology Course
News Type: Other Events

This well established course runs for its 22nd time in the Royal College of Physicians of Edinburgh

To read more, to view the programme and to find out how to register visit the website > here.

Should you have any questions please contact: Christine Berwick, Education Coordinator at .

We look forward to receiving your booking.

06/02/18 Improving Quality in Liver Services Event
News Type: Other Events

The improving Quality in Liver Services accreditation scheme will host a second event at RCP North, in Liverpool on 6th of February 2018. This is for services interested in learning more about the scheme and for those who were unable to make the first event in London.

The aim of the day is to provide further understanding of the scheme and the process. Delegates will have an opportunity to speak to the leads of scheme and to ask questions or advice. Liver services are again encouraged to join the RCP North event where they can network and share best practice.

Date: February 6 2018
Venue: RCP North, Royal College of Physicians North, Level 3, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX
Time: 10:00am – 13:00pm

All interested parties are welcome to attend. Please forward the invitation to your colleagues to ensure all interested parties are invited;  Download IQILS launch event 0.2 Feb 18.pdf

To book a place please RSVP with the names of those who wish to attend from your service to .

Lunch will be provided. Please include any dietary or accessibility requirements.

09/02/18 - 11/02/18 Advances and Perspectives in Hepatology, Budapest Liver Meeting
News Type: Other Events

The scientific conference is to be held in Budapest, Hungary, between February 9 and 11, 2018 and features many of the leading experts in the field of hepatology.

The programme will address five key topics in current hepatology:

  • nonalcoholic fatty liver disease, which begins to dominate the field as we await answers to fundamental questions in its diagnosis, management, and outcomes;
  • chronic hepatitis C, which is now easy to cure due to revolutionary pharmaceutical advances yet global eradication faces major challenges;
  • complications of liver disease, which will be a smorgasbord of expert opinions on how to manage adverse outcomes and to provide comfort and dignity for the patient with cirrhosis;
  • hepatocellular carcinoma, which is a globally prevalent and dismal outcome of chronic liver disease with slowly mounting hope for better survival through personalized treatment; and
  • frontiers in hepatology, reviewing some of the most exciting advances such as the role of gut microbiota, the power of big data, and the promise of engineered hepatocytes. This carefully balanced program will be delivered by an internationally renowned faculty from Europe and the Americas.

To find out more about the conference and how to register visit the website > here

22/02/18 Basic to Translational: Current Concepts of Liver Immunology Meeting
News Type: BASL Endorsed Events

BSI London Immunology Group presents a one day meeting on key themes in basic and translational liver immunology.

The meeting is endorsed by BASL and is taking place at The Royal College of Anaesthetists, Churchill House, 35 Red Lion Square, London WC1R 4SG.

Date: Thursday, 22 February, 2018 - 09:00 to 18:00.

Further information can be found here >  Download BSI Liver Meeting Feb 18 flyer -v1.pdf

and a programme here >  Download BSI Liver meeting Feb 2018.pdf 


  • Lymphoid Cells and liver immunity
  • Innate immune cells and the liver
  • Novel concepts in liver immunology and immunotherapy
  • Selected Abstracts

Along with guest speakers there will be 3 oral presentations and posters to be selected from abstracts. A prize will be awarded for the best oral presentation.
Please submit your 250 word (max) abstract to  - the abstract deadline is 18th December 2017

There is limited capacity so please register early to avoid disappointment. Register by clicking > here.


  • BSI/BASL Members – Early Bird Rate before 22nd January 2018 - £50 / from 22nd January - £65
  • Student/Concessionary BSI/BASL Members – Early Bird Rate before 22nd January 2018 - £20 / from 22nd January - £30.

If you have any enquries please contact the London Immunology Group > here. 

23/02/18 RCPath Conference: Liver Biopsy in the Assessment of Medical Liver Disease - London
News Type: Other Events

This well established course designed for pathologists and hepatologists runs for the 8th time in February 2018. The course is intended to provide a practical diagnostic approach to reporting liver biopsies from patients with medical liver diseases.

To view the programme and to register visit the RCPath website by clicking > here.

Venue: Royal College Of Psychiatrists, 21 Prescot St, Whitechapel, London E1 8BB.

08/03/18 - 09/03/18 Inherited disorders of metabolism affecting the liver: management and outcome - Leuven (Belgium)
News Type: Other Events

A course jointly organised by the Hepatology and Metabolic Center, Leuven and the Charles Dent Metabolic Unit, London. This course will include up to date, state of the art lectures and debates, with expert European speakers, regarding current evidence for predicting / preventing complications, and treatment, including transplant and its outcomes, in inherited liver disease. Disorders covered will include the glycogen storage disorders, disorders of glycosylation, lysosomal acid lipase deficiency, disorders of bile acid synthesis, the organic acidemias, Wilson disease and mitochondrial disease. The latest advances in gene therapy and stem cell therapy for metabolic liver disease and the role of circulating microRNAs will also be discussed.

The course is aimed at: Consultants, senior trainees and scientists with a specific interest in inherited metabolic disease, hepatology or liver transplant. Paediatric or adult practice.

View the full details and programme here >  Download Hepatic disease_Leuven 8-9 March 2018.pdf

Fees - the course fees of 450€ cover:

  • 2 nights hotel accommodation (7th and 8th March) including breakfast.
  • Lunch, coffee and dinner during the course.

A local fee of 315€ is granted if accommodation is not needed.

Participants are responsible for their own travel arrangements to and from the course. Fees are not refundable.

Registration process and deadline
The registration form should be completed on-line: and submitted with your curriculum vitae in English. No payment is required at this stage.
Deadline for registration is 10th of January 2018.

Selection criteria and review process: 
Candidates will be selected based on their background, experience and geographical breakdown.
The scientific organising committee will review the applications and select participants.
Selection decisions will be announced within 10 days following the deadline for registration.

Accreditation - an application will be made for European CME (EACCME).


We are pleased to announce that the liver disease quality standard (QS152) has been published on the NICE website today.

You can view the quality standard by clicking > here.

BASL has formally supported the liver disease quality standard.

Join BASL Ward Membership Today - £100 per annum for up to 5 members per ward.

Download a flyer for your noticeboard -   Download BASLNF Ward Membership Flyer May 17.pdf.

To find out how to apply click here

Click here to view the BASL Newsletter - October 2017.

Click here to view the Alcohol Health Alliance Newsletter - November 2017. 

Click here to view the NICE Newsletter  - October 2017.

Learning Toolkits

The BASL Nurse Toolkits were developed following conversations with nurse specialists. These and a later email survey identified training needs to help nurses meet the liver nurse competencies. To access the Learning Toolkits sign in as a BASL Member and click on Manage Account

Quick Links

BASL is connected to a number of national initiatives that you might be interested in.